J0605 HCPCS Level II code: Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)
J0605 is the HCPCS code for “Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0605Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)
Short description: Sucroferric oxyhydroxide 5mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J0605 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Other carrier priced
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2025
Where J0605 sits
- 1J codesDrugs administered other than orally
- 2Active code J0605Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0605 mean?
J0605 is the HCPCS code for “Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0605?
CMS lists J0605’s Medicare coverage as “Carrier judgment” and its pricing as “Other carrier priced”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0605
All J codesJ0599Injection, c-1 esterase inhibitor (human), (haegarda), 10 unitsJ0600Injection, edetate calcium disodium, up to 1000 mgJ0601Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)J0602Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)J0603Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)J0604Cinacalcet, oral, 1 mg, (for esrd on dialysis)J0606Injection, etelcalcetide, 0.1 mgJ0607Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)J0608Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)J0609Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)J0610Injection, calcium gluconate (fresenius kabi), per 10 mlJ0611Injection, calcium gluconate (wg critical care), per 10 ml